Amgen: Blockbusters, Emerging Therapies, And Investment Potential

Amgen Inc. (NASDAQ: AMGN ) is a biotechnology powerhouse with an excellent track-record on developing and commercialising products targeting four main therapeutic areas: general medicine, rare disease, oncology and inflammation/immunology. In their Q3 2024 financial report, the company showed 24% revenueOriginally a Biologist, M.Sc in Biomedicine, PhD in Bioengineerings, and +20 years experience in the research and development of novel Cell & Gene Therapies (CGT) tackling several clinical needs including or ...